about
Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysisRadioisotopes for metastatic bone painBisphosphonates for advanced prostate cancerBisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysisOsteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature reviewAGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.WITHDRAWN: Radioisotopes for metastatic bone pain.Use of intravenous bisphosphonates in older women with breast cancerMicroglial depletion using intrahippocampal injection of liposome-encapsulated clodronate in prolonged hypothermic cardiac arrest in rats.Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.The evolving role of zoledronic acid in early breast cancerLung cancer presenting as acrometastasis to the finger: a case reportZoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.Predicting skeletal complications in metastatic breast cancer raises challenges.Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials.Improving management of patients with advanced cancerThe science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsBiochemical markers of bone turnover and clinical outcomes in men with prostate cancerBisphosphonates and pathologic complete response to taxane- and anthracycline-based neoadjuvant chemotherapy in patients with breast cancer.Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.Bony metastases: assessing response to therapy with whole-body diffusion MRI.Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients.Treatment of Bone Metastases in Patients with Advanced Breast Cancer.The health of women treated for breast cancer: A challenge in primary care.Bone matters in lung cancer.Management of arthralgias associated with aromatase inhibitor therapyBone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the artImportance of antiresorptive therapies for patients with bone metastases from solid tumors.Protection of bone in premenopausal women with breast cancer: focus on zoledronic acidThe management of osteoporosis in breast cancer survivors.A primer of bone metastases management in breast cancer patients.Ibandronate: The loading dose concept in the treatment of metastatic bone pain.Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.As if the cancer wasn't enough! Understanding and treating the pain that comes with cancer.Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment optionsBisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate!Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment.Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.
P2860
Q21132670-A5653C8B-9A1A-41E4-93D9-777BCCDC9FE7Q24235589-D61B79A8-01F3-4EF6-B9D5-5685657C10B8Q24244161-D6EFA724-927C-432A-87B5-84ED50D27699Q24608900-14EF7A92-2117-4284-A63D-960E360EDB37Q27008336-D376DCE5-89C4-4BC5-88FF-876C5283590FQ30318240-CEB93BAB-D3A3-4F8C-8A64-E642FF2B89B6Q33440341-566FCD33-B0F6-4EA7-966D-F44B6EB6E87DQ33666930-C0D82305-2142-476D-81C3-E564C539295BQ33668297-5199700F-F38E-4F36-B96F-235920E01886Q33703527-1D891515-FC12-447D-AD01-21667806F044Q33915978-DACB1A5D-723F-4341-949A-65BCB31C7A7AQ33943078-D2694539-559D-4DE1-84CE-01CE38BC84F4Q34025648-3BB221EC-06D2-4311-9366-9BE144278444Q34247639-4B46EB01-9632-4B82-BC45-ADBB1582DA9FQ34320376-4146CA64-3702-4EA7-B30A-68072C358E10Q34413634-7FBA0F66-9E80-401A-9CF6-C10AB022985BQ34617864-0D9759F6-777A-4E7F-A525-6D61E3D6C8CAQ35022212-5601E596-FF50-40E7-9730-840BCF049F98Q35172721-530CC896-44F0-4AB6-91CF-40378DB5D293Q35583788-1FC6AC45-6247-4657-BE60-4E86C92C751CQ35697593-47406726-CDF3-45B7-9B23-676A268586C6Q35750453-A4EB9B30-092E-4207-A893-A14AEF14495EQ35920063-463144E9-180F-4A60-B3B0-988F0474A1F7Q35989786-731F2FAF-219D-4A5C-BFC8-D07882760798Q36036088-EA5C99CF-26F5-49AE-A555-132CED42357EQ36090880-49C95CBE-FC50-4A35-9D64-939E370D076CQ36182345-6BD00030-4017-4784-8B81-BA30DB4C72B3Q36274936-E003723C-1A9C-4916-9FD5-11442C7353CAQ36278556-712CA008-E10E-45F0-83E6-06F6C0B0432BQ36283738-82AA1C01-128F-4273-AEBD-9DB728264857Q36394320-86EDBA50-C171-433B-AA60-30517634FD17Q36405775-373662DB-FAF6-418E-96B6-052CFE14005DQ36410656-F0C0C583-ECC9-478B-A5C5-3E124323F41EQ36661448-752D9815-687F-4A84-8BBE-EDDB6A42BA14Q36696468-1BC4BB83-31D0-489B-AFE7-4F01D8543FFDQ36792308-997FED8D-C706-4279-9FF6-400507741298Q36798749-17FCF348-E530-49BD-917C-69C770EDC59AQ36963360-624426D8-946B-4F39-BA6A-BF4BBDD4BF57Q37166882-87081FE0-E86A-492D-BF5E-D49AFD85A845Q37193002-F0DD624B-9899-4348-849C-4A9A4547035E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Bisphosphonates for breast cancer
@ast
Bisphosphonates for breast cancer
@en
Bisphosphonates for breast cancer
@en-gb
Bisphosphonates for breast cancer
@nl
type
label
Bisphosphonates for breast cancer
@ast
Bisphosphonates for breast cancer
@en
Bisphosphonates for breast cancer
@en-gb
Bisphosphonates for breast cancer
@nl
prefLabel
Bisphosphonates for breast cancer
@ast
Bisphosphonates for breast cancer
@en
Bisphosphonates for breast cancer
@en-gb
Bisphosphonates for breast cancer
@nl
P2860
P1476
Bisphosphonates for breast cancer
@en
P2093
M Stockler
N Pavlakis
P2860
P304
P356
10.1002/14651858.CD003474.PUB2
P50
P577
2005-07-20T00:00:00Z